Inventor
HEGE KRISTEN MAE
US12 patents
Patents
12 patentsUS9505764B2Nov 29, 2016
Treatment of cancer with dihydropyrazino-pyrazines
SIGNAL PHARM LLC11 citations83
US9493466B2Nov 15, 2016
Treatment of cancer with TOR kinase inhibitors
SIGNAL PHARM LLC7 citations83
US9474757B2Oct 25, 2016
Methods for treating cancer using TOR kinase inhibitor combination therapy
SIGNAL PHARM LLC16 citations83
US9375443B2Jun 28, 2016
Method for treating advanced non-small cell lung cancer (NSCLC) by administering a combination of a TOR kinase inhibitor and azacitidine or erlotinib
SIGNAL PHARM LLC12 citations83
US9358232B2Jun 7, 2016
Methods for treating cancer using TOR kinase inhibitor combination therapy
SIGNAL PHARM LLC13 citations83
US9630966B2Apr 25, 2017
Treatment of cancer with dihydropyrazino-pyrazines
SIGNAL PHARM LLC4 citations71
US11166950B2Nov 9, 2021
Treatment of cancer with TOR kinase inhibitors
SIGNAL PHARM LLC0 citations62
US9937170B2Apr 10, 2018
Treatment of cancer with TOR kinase inhibitors
SIGNAL PHARM LLC1 citations62
US10391092B2Aug 27, 2019
Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
SIGNAL PHARM LLC0 citations51
US10183019B2Jan 22, 2019
Treatment of cancer with dihydropyrazino-pyrazines
SIGNAL PHARM LLC0 citations51
US9980963B2May 29, 2018
Treatment of cancer with dihydropyrazino-pyrazines
SIGNAL PHARM LLC0 citations51
US9937169B2Apr 10, 2018
Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
SIGNAL PHARM LLC0 citations51